Press coverage about Omnicare (NYSE:OCR) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Omnicare earned a news impact score of 0.22 on Accern’s scale. Accern also gave news coverage about the healthcare company an impact score of 44.0523281504025 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

ILLEGAL ACTIVITY NOTICE: “Omnicare (OCR) Receives Media Impact Rating of 0.22” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/07/17/omnicare-ocr-receives-media-impact-rating-of-0-22.html.

Omnicare Company Profile

Omnicare, Inc is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings.

Receive News & Ratings for Omnicare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.